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Abstract
Background: Obesity is known to affect cell-mediated immune responses. Recent studies have revealed that genetic
polymorphisms in the fat mass and obesity associated (FTO) gene are related to human obesity. We hypothesize that
this gene may also play a role in the risk of immune-related infectious diseases such as tuberculosis.
Methods: This case–control study included 1625 pulmonary tuberculosis cases and 1570 unaffected controls recruited
from the Jiangsu province in China. Single nucleotide polymorphisms (SNPs), rs9939609 and rs8050136, in the FTO
gene were genotyped using TaqMan allelic discrimination assays. Odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated using the unconditional logistic regression model.
Results: We observed a significant association between the genetic polymorphism rs9939609 and tuberculosis risk.
Compared with the common genotype TT, individuals carrying AA had a significantly increased risk, with an OR of 3.77
(95% CI: 2.26-6.28). After adjusting for potential confounders, the relationship remains significant. An additive model
showed that carriers of an allele A had a 26% increased risk of tuberculosis compared with the T allele (OR: 1.26, 95%
CI: 1.08-1.48). Compared with the common haplotype rs9939609T-rs8050136C, the haplotype rs9939609A-rs8050136C
was related to an increased risk of tuberculosis (OR = 6.09, 95% CI: 3.27-12.34).
Conclusions: The FTO polymorphism rs9939609 is associated with a risk of pulmonary tuberculosis in the Chinese
population.
Background
Tuberculosis (TB), a chronic infectious disease caused by
Mycobacteria tuberculosis and continues to be a major
global health threat, particularly in developing countries.
In 2012, an estimated 8.6 million new cases occurred, and
approximately 1.3 million people died worldwide due to
TB (WHO. Global tuberculosis report 2013). Malnutri-
tion, tobacco smoking, immunosuppressive treatment,
diabetes, indoor air pollution, crowding, migration, aging
and poverty have all been recognized as possible risk fac-
tors [1-5]. Among these factors, weight-related problems
have gained more focus recently because several studies
have revealed that obesity is not only associated with ma-
lignancies (e.g., breast cancer and colorectal cancer) [6],
cardiovascular disorders [7] and type 2 diabetes [8] but is
also related to multiple infectious diseases [9].
Until recently, little was known about genetic determi-
nants of obesity, with the exception of a few monogenic,
extreme forms [10]. It is estimated that 40% to 90% vari-
ation in weight or obesity is attributed to genetic factors,
according to twins or adoption studies [11-15]. Since then,
genome-wide association studies (GWAS) have become
available [16], and great advances have been made in ex-
ploring the association of genetic polymorphisms with hu-
man diseases and traits [17,18]. The first single nucleotide
polymorphism (SNP) robustly related to body mass index
(BMI) was mapped to one gene in 2007. This gene, now
known as FTO (fat mass and obesity associated, Gene ID:
79068), has been repeatedly found to affect obesity in
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different populations [19-22]. The FTO gene is located on
chromosome 16q12.2, which is well conserved in verte-
brate species (e.g., fish and chicken) and plays a role in
regulation of food intake [23]. This gene encodes a pro-
tein with a novel C-terminal α-helical domain and an
N-terminal double-strand β-helix domain. In vitro, the
FTO protein can demethylate single-stranded RNA or
DNA, but the exact physiological and function is still
unknown [24]. The genetic polymorphisms rs9939609
and rs8050136 within the FTO gene were found to be
significantly associated with obesity in different popula-
tions [25-28], including the Chinese population [29-32].
Recent studies have further shown the effects of the
FTO gene on the risk of BMI-related outcomes such as
diabetes [33], neural tube defects [33] and Alzheimer’s
disease [34]. Although the effects of obesity on the de-
velopment of metabolic and cardiovascular problems
are well studied, much less is known about its impact on
the infectious diseases. Obesity, similar to other states of
malnutrition, is known to impair immune function, alter
leukocyte counts and affect cell-mediated immune re-
sponses [35]. The impairment of the immune function
leads to an increased susceptibility of the host to pathogens
such as influenza, Mycobacterium tuberculosis, coxsackie
virus, Helicobacter pylori and encephalomyocarditis virus
[9]. We hypothesize that the FTO gene may play an im-
portant role in the risk of immune-related human infec-
tious diseases such as tuberculosis. To test this hypothesis,
we performed a case–control study to assess the associ-
ation of two common FTO polymorphisms (rs9939609
and rs8050136) with pulmonary tuberculosis in a Chinese
population.
Methods
Study subjects and data collection
This case–control study included 1625 pulmonary tu-
berculosis cases and 1570 unaffected controls recruited
from Jiangsu province in China. All cases and controls
were unrelated Han Chinese population. The cases
were recruited from local Centers for Disease Control
and Prevention and TB dispensaries. All cases were
diagnosed by specialized doctors based on clinical
signs, chest x-ray examination, sputum smear tests or
sputum culture. Controls were recruited through their
participation in local community-based health examin-
ation programs. Those with a history of tuberculosis or
malignancy were excluded. Controls were frequency
matched to cases by sex and age. None of the cases and
controls had an HIV-positive history. Trained interviewers
administered a questionnaire to collect data on their
demographic characteristics, tobacco smoking, alcohol
consumption and health care-seeking history. A blood
sample was collected from each participant for molecular
analysis.
Genotyping
We extracted genomic DNA from peripheral blood sam-
ples by proteinase K digestion and a modified phenol-
chloroform protocol. The DNA was frozen at −20°C until
genotyping. Genotype determination of rs9939609 and
rs8050136 in the FTO gene was carried out using TaqMan
allelic discrimination assays on the ABI 7900HT Real-
Time PCR System (Applied Biosystems, Foster City, CA,
USA) and was ascertained using the SDS software (version
2.3). The sequence specific forward and reverse primers
and Taqman MGB probes are listed in Table 1. To avoid
batch bias, we allocated DNA samples of cases and con-
trols in each plate with no discrepancies between amplifi-
cation reaction conditions. The overall calling rate was
99.2% for rs9939609 and 98.4% for rs8050136. We ran-
domly selected samples with different genotypes for gene
sequencing. The consistent rate was 100%.
Statistical analysis
Data were entered with EpiData 3.1 (Denmark) and ana-
lyzed using STATA 10.0 (StataCorp, College Station, TX,
USA). Student’s t-test (for continuous variables) and the
χ2 test (for categorical variables) were used to analyze the
differences in demographic variables and potential risk
factors between cases and controls. Hardy-Weinberg equi-
librium (HWE) was tested using a goodness-of-fit χ2 test
by comparing the observed genotype frequencies with the
Table 1 Primers and probes used to detect SNPs
SNPs Sequence (5′-3′) Detecting allele
rs9939609 F CTAACATCAGTTATGCATTTAGAATGTCTG
R CCCACTCCATTTCTGACTGTTACC
Probe-T FAM-CTGTGAATTTTGTGATGC-MGB Allele T
Probe-A HEX-CTGTGAATTTAGTGATGCA-MGB Allele A
rs8050136 F CAGTGCCAGCTTCATAGCCTAGT
R CCATGAGTCCATCTCTACAGTTTACC
Probe-C HEX-CTGTGGCAATCAATAT-MGB Allele C
Probe-A FAM-CTGTGGCAATAAATA-MGB Allele A
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expected ones among the controls to ensure that the al-
leles were independently segregated. To evaluate the ef-
fects of genetic polymorphisms of the FTO gene on the
risk of tuberculosis, we calculated odds ratios (ORs) and
95% confidence intervals (CIs) using the unconditional lo-
gistic regression model. To avoid potential confounding, we
further adjusted by age, sex, tobacco smoking and alcohol
consumption. To analyze the effect of SNPs comprehen-
sively, we applied three different genetic models: the addi-
tive model, the dominant model and the recessive model.
Haplotype analysis on SNP rs9939609 and rs8050136 was
performed using the phase 2.1 software.
Ethical approval
The study was approved by the Institutional Review Board
of Nanjing Medical University. Informed consent was ob-
tained for both the interviews and the blood samples.
Results
The genotype distributions of two SNPs were all in
HWE in the controls (P = 0.381 for rs9939609; P = 0.368
for rs8050136). The general characteristics of cases and
controls are shown in Table 2. In total, 1583 cases and
1544 controls were successfully genotyped and analyzed.
Due to the frequency matching, there was no significant
difference in the distribution of both age and sex between
the groups. The proportion of ever smokers was 52.64%
among cases which was significantly higher than that
among controls (34.84%). However, alcohol consumption
was inversely related to tuberculosis, where 22.50% of the
cases vs. 26.19% of the controls had a history of alcohol
consumption (P = 0. 017).
There was a significant association between rs9939609
(T > A) and the risk of tuberculosis. Compared with the
common genotype TT, those carrying the AA genotype
had a significantly increased risk, with an OR of 3.77
(95% CI: 2.26-6.28). After adjusting for potential con-
founders (sex, age, smoking and alcohol consumption),
the association remained significant [adjusted OR: 3.57
(95% CI: 2.13-6.01)]. As shown in Table 3, allele A carriers
had a significantly increased risk among both clinical
tuberculosis cases [OR: 1.26 (95% CI: 1.08-1.48), P =
0.004] and smear-positive cases [OR: 1.21 (95% CI:
1.02-1.44), P = 0.030]. The additive model showed that
with each increased number of A alleles, the risk for tu-
berculosis increased accordingly [crude OR: 1.23 (95%
CI: 1.06-1.42), adjusted OR: 1.22 (95% CI: 1.05-1.42)].
Stratified analysis revealed that the effect of AA genotype
of rs9939609 on tuberculosis was more evident among
men, ever smokers and alcohol drinkers (Tables 4 and 5).
However, the heterogeneity wasn’t significant across the
strata. A significant association between the polymor-
phisms of rs8050136 and tuberculosis was only observed
among never drinkers. Compared with the wild type CC,
the OR(95% CI) was 0.22(0.06-0.83) for rs8050136 AA geno-
type. However, it was not significant after the Bonferroni
multiple comparison correction.
Linkage disequilibrium (LD) was found between these
SNPs of FTO (D’ = 0.98, r2 = 0.94). A haplotype analysis
was carried out, and the rs9939609A-rs8050136C haplo-
type significantly increased the risk of TB (OR = 6.09, 95%
CI: 3.27-12.34) (Table 6).
To determine the potential functional effect of the SNP,
we used the prediction tools SNPinfo (http://snpinfo.
niehs.nih.gov/snpinfo/snpfunc.htm) and Regulome DB
(http://www.regulomedb.org/). The RegulomeDB showed
that rs8050136 was the binding site for the transcription
factor (TF) EP300. The RegulomeDB score was 4 (sup-
porting data: TF binding +DNase peak). No data were
provided for the functional prediction of rs9939609.
Discussion
This case–control study investigated the association be-
tween genetic polymorphisms of the FTO gene and tu-
berculosis in a Chinese Han population. This is the first
study, to our knowledge, revealing the effect of genetic
variations of intron 1 SNP rs9939609 of FTO on the risk
of tuberculosis.
Immunocompetence is dependent on nutritional status
and can be negatively affected by malnutrition and re-
lated disorders, including obesity. Epidemiological data
support the hypothesis that obesity can affect immune
function in humans [9]. Obesity has been shown to be

























*There are some missing values.
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Table 3 The association between two SNPs within the FTO gene and the risk of tuberculosis
SNPs Control
(n = 1544)
Total cases (n = 1583) Smear-positive cases (n = 1077)
n (%) n (%) cOR (95% CI) P aOR (95% CI) P n (%) cOR (95% CI) P aOR (95% CI) P
rs9939609 (T > A)
TT 1250(80.91) 1258(79.52) 1 1 856(79.48) 1 1
AT 275(17.86) 253(15.94) 0.91(0.75-1.10) 0.316 0.91(0.74-1.10) 0.316 182(16.90) 0.96(0.78-1.18) 0.723 0.96(0.77-1.19) 0.699
AA 19(1.23) 72(4.54) 3.77(2.26-6.28) <0.001 3.57(2.13-6.01) <0.001 39(3.62) 2.99(1.73-5.17) <0.001 2.84(1.61-5.01) <0.001
T allele 2767(89.84) 2777(87.35) 1 1894(87.93) 1
A allele 313(10.16) 397(12.51) 1.26(1.08-1.48) 0.004 260(12.07) 1.21(1.02-1.44) 0.030
Add 1.23(1.06-1.42) 0.006 1.22(1.05-1.42) 0.011 1.20(1.01-1.41) 0.035 1.18(0.99-1.40) 0.059
Dom 1.10(0.92-1.31) 0.296 1.09(0.91-1.30) 0.374 1.10(0.90-1.34) 0.343 1.09(0.89-1.33) 0.424
Rec 3.82 (2.30-6.37) <0.001 3.64(2.17-6.10) <0.001 3.02(1.73-5.25) <0.001 2.86(1.62-5.04) <0.001
rs8050136 (C > A)
CC 1250(80.91) 1265(79.96) 1 1 863(80.13) 1 1
AC 282(18.31) 311(19.60) 1.09(0.91-1.30) 0.347 1.08(0.19-1.26) 0.408 210(19.5) 1.08(0.89-1.32) 0.448 1.07(0.87-1.32) 0.513
AA 12(0.78) 7(0.44) 0.58(0.23-1.47) 0.248 0.48(0.19-1.26) 0.136 4(0.37) 0.48(0.16-1.50) 0.209 0.40(0.13-1.28) 0.123
C allele 2774(90.06) 2849(89.76) 1 1936(89.88) 1
A allele 306(9.94) 325(10.24) 1.03 (0.88-1.22) 0.690 218(10.12) 1.02(0.85-1.23) 0.826
Add 1.04(0.88-1.23) 0.632 1.02(0.86-1.22) 0.804 1.03(0.85-1.24) 0.789 1.01(0.83-1.22) 0.957
Dom 1.07(0.90-1.28) 0.461 1.05(0.88-1.27) 0.569 1.06(0.87-1.28) 0.590 1.04(0.85-1.28) 0.702
Rec 0.57 (0.22-1.44) 0.234 0.48(0.18-1.24) 0.127 0.48(0.15-1.48) 0.200 0.40(0.12-1.26) 0.117*



















influenced by genetic determinants. In 2007, the first
common genetic variant in the FTO gene was identified.
FTO is a large gene with nine exons spanning more than
400 kb on chromosome 16, and all of the SNPs identi-
fied so far are located in the first and largest intron of
the gene [36]. FTO is predominantly expressed in the
brain, particularly in the hypothalamus, and plays a key
role in the control of energy homeostasis [37]. In studies
with mice, the expression of FTO in the arcuate nucleus
of hypothalamus decreased following a 48-hour fast and
increased after 10 weeks of exposure to a high-fat diet
[38,39]. In humans, FTO appears to be essential for the
normal development of major organ systems, such as
the central nervous and cardiovascular system [36]. The
first SNP strongly associated with BMI and obesity was
located in the FTO gene, and this has been subsequently
replicated in multiple populations [25]. Since Fralying
et al. found that the variant of rs9939609 could increase
the risk of developing obesity by 31%, numerous studies
covering multiple populations subsequently focused on
this SNP [40-42]. Li et al. genotyped rs9939609 in a Chin-
ese population and found that the A allele was strongly as-
sociated with obesity and overweight [43]. The odds ratios
for the allele A vs. T were 1.447 for obesity vs. normal
weight (95% CI: 1.104-1.896) and 1.363 for overweight vs.
normal weight (95% CI: 1.149-1.617) [43]. Xi et al. geno-
typed 11 SNPs of FTO gene in the Chinese children (6–18
years) and replicated the association of FTO rs9939609
with the risk of central obesity (OR:1.29, 95% CI:1.10-
1.50) [40]. The association between rs9939609 poly-
morphism and obesity was also supported by other studies
in China [29,41,42]. Though results of our present study
do not directly support the role of FTO in obesity risk, it
is plausible that its effect on tuberculosis occurs through
obesity-related immunocompetence.
In addition to obesity, the FTO rs9939609 polymorph-
ism was found to be associated with type 2 diabetes in
Vietnamese (OR per A allele = 1.61, 95% CI: 1.06-2.44)
[44], South Asians (OR per A allele = 1.18, 95% CI: 1.07-
1.30) [45], and Chinese (OR for allele A = 1.31, 95% CI:
1.10-1.55) [43]. Interestingly, there is growing evidence
regarding diabetes as a risk factor for tuberculosis, and it
might affect a patient’s disease presentation and treat-
ment response [4,46,47]. Uncontrolled diabetics seem to
have more cavities and higher positive smear rates and
to show a lack of culture conversion after two months of
antituberculosis therapy [48]. At the public health level,
the diabetes epidemic could be one reason why efforts
to reduce the global incidence of tuberculosis are having
little effect, despite the high case detection rates and
cure rates [47].
In this study, a LD was found between rs9939609 and
rs8050136. The haplotype rs9939609A-rs8050136C was
related with an increased risk of tuberculosis. Previous
studies have revealed that individuals who carry a par-
ticular SNP allele at one site often predictably carry
specific alleles at other nearby sites. This correlation is
known as LD and a particular combination of alleles
along a chromosome is termed as the haplotype [49].
The relationship between causal mutations and the
haplotypes have been regarded as a tool for genetic
researches––first finding association to a haplotype,
and then subsequently identifying the causal mutations
that it carries [49].
Table 4 The association between two SNPs within the FTO gene and the risk of tuberculosis stratified by sex
SNPs Male (n = 2290) Female (n = 837)
n (%) OR (95% CI)a Pa n (%) OR (95% CI)a Pa
rs9939609 (T > A)
TT 1823(79.61) 1 685 (81.84) 1
AT 396(17.29) 0.93(0.74-1.16) 0.508 132 (15.77) 0.85(0.58-1.24) 0.397
AA 71(3.10) 4.15(2.23-7.70) <0.001 20 (2.39) 2.46(0.93-6.47) 0.069
Add 1.27 (1.06-1.51) 0.008 1.09(0.80-1.47) 0.590
Dom 1.13(0.91-1.39) 0.257 0.98(0.68-1.40) 0.893
Rec 4.20(2.27-7.79) <0.001 2.52(0.96-6.63) 0.061
rs8050136 (C > A)
CC 1827 (79.78) 1 688 (82.20) 1
AC 448 (19.56) 1.12(0.90-1.39) 0.301 145 (17.32) 0.98(0.68-1.42) 0.924
AA 15 (0.66) 0.53(0.18-1.52) 0.237 4 (0.48) 0.35(0.04-3.38) 0.364
Add 1.06(0.86-1.29) 0.591 0.93(0.66-1.32) 0.692
Dom 1.09(0.88-1.35) 0.413 0.51(0.18-1.49) 0.220
Rec 0.51(0.18-1.49) 0.220 0.35(0.04-3.38) 0.365
aadjusted for age, sex smoking and alcohol drinking where appropriate, Add additive model, Dom dominant model, Rec recessive model, OR odds ratio,
CI confidence interval.
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Table 5 The association between two SNPs within the FTO gene and the risk of tuberculosis stratified by smoking and alcohol drinking
SNPs Smoking Alcohol drinking
Never (n = 1751) Ever (n = 1366) Never (n = 2325) Ever (n = 747)
n (%) OR (95% CI)a Pa n (%) OR (95% CI)a Pa n (%) OR (95% CI)a Pa n (%) OR (95% CI)a Pa
rs9939609 (T > A)
TT 1421( 81.15) 1 1078(78.92) 1 1868 (80.34) 1 594 (79.52) 1
AT 292(16.68) 0.98 (0.76-1.28) 0.906 235(17.20) 0.81(0.60-1.09) 0.163 394 (16.95) 0.91(0.72-1.13) 0.391 125 (16.73) 0.88(0.59-1.31) 0.536
AA 38( 2.17) 2.87( 1.43-5.77) 0.003 53(3.88) 4.69(2.08-10.59) <0.001 63 (2.71) 2.42(1.36-4.32) 0.003 28 (3.75) 15.39(3.78-134.54) <0.001
Add 1.20(0.98-1.48) 0.083 1.23(0.99-1.54) 0.065 1.12 (0.94-1.34) 0.200 1.51 (1.13-2.03) 0.006
Dom 1.11(0.87-1.42) 0.388 1.05(0.80-1.38) 0.720 1.03 (0.83-1.27) 0.799 1.27 (0.88-1.82) 0.196
Rec 2.88(1.44-5.77) 0.003 4.86(2.16-10.96) <0.001 2.46 (1.39-4.39) 0.002 14.65(3.44-62.34) <0.001
rs8050136 (C > A)
CC 1428(81.55) 1 1078(78.92) 1 1878 (80.77) 1 591 (77.49) 1
AC 316(18.05) 1.13(0.88-1.45) 0.336 276(20.20) 1.02(0.77-1.35) 0.888 434 (18.67) 1.05(0.84-1.30) 0.673 150 (20.08) 1.18(0.82-1.69) 0.383
AA 7(0.40) 0.22(0.03-1.81) 0.157 12(0.88) 0.68(0.21-2.17) 0.512 13 (0.56) 0.22(0.06-0.83) 0.025 6 (0.80) 2.12(0.38-11.68) 0.389
Add 1.06(0.83-1.34) 0.644 0.98(0.76-1.27) 0.896 0.96(0.78-1.18) 0.692 1.21(0.87-1.70) 0.260
Dom 1.10(0.86-1.41) 0.460 1.00(0.76-1.32) 0.988 1.00(0.81-1.24) 0.964 1.20(0.84-1.72) 0.313
Rec 0.21(0.03-1.76) 0.151 0.67(0.21-2.16) 0.507 0.22(0.06-0.82) 0.024 2.05(0.37-11.29) 0.409



















In the present study, we observed the role of common
FTO rs9939609 SNP in the risk of tuberculosis, which
supports the hypothesis that genetic polymorphisms of
the FTO gene affect the host’s susceptibility to infectious
diseases. We believe that the effect of FTO-rs9939609 on
the risk of tuberculosis may not solely be attributed to its
role in the risk of obesity. The altered human immune
function related to these genetic variants can explain, at
least in part, why some people resist tuberculosis infection
more successfully than others [50,51]. This finding may
help distinguish individuals who are at higher risks for tu-
berculosis and implement effective interventions to pre-
vent and control the disease.
HWE test is commonly used as an initial quality check
procedure in genetic association studies. Departure from
HWE (DHWE) may suggest a higher risk of genotyping
errors [52]. In the current study, HWE was observed
among controls for either the SNP rs9939609 or the
SNP rs8050136, but the P value from classical goodness-
of-fit test was less than 0.05 in cases. In general, the
HWE test assumes that the genotypes are sampled from
the general population, and therefore the HWE tests are
performed based on the controls. If the entire popula-
tion is in perfect HWE, the presence of a genetic associ-
ation implies that neither cases nor controls can be in
HWE. Because the proportion of affected subjects in a
population is small, the degree of DHWE is expected to
be stronger in cases than in controls. Therefore, as an
indicator of genotyping quality, compatibility with HWE
should be investigated in control groups only [53]. In co-
hort studies, no DHWE is expected, and therefore the
entire sample should be genotyped for testing HWE
[53]. Recently, some authors have shown that when the
disease is common in the general population, the con-
trols do not accurately represent the general population.
Therefore, using only controls for HWE testing can
result in highly inflated type I error and might lead
investigators to discard potential causal SNPs [52].
Wittke-Thompson et al. suggest that if a DHWE in
cases or in both cases and controls is detected, it does
not necessarily imply genotyping errors [54]. Rather than
discarding the data, the underlying disease-genotype associ-
ation should be investigated. The association may explain
the observed DHWE. If not, other possible explanations
such as “genotyping error, chance, and failure of as-
sumptions underlying HWE expectations” should be
explored [55]. To detect genotyping errors, repeated
genotyping of the same samples is preferable over HWE
testing. In the current study, we allocated DNA samples
of cases and controls in each plate with no discrepancies
between amplification reaction conditions. We ran-
domly selected 5% samples to re-genotype and the
consistent rate was more than 99%. We also randomly
selected samples with different genotypes for gene sequen-
cing and the consistent rate was 100%. Thus we believe
that the DHWE in cases can’t be attributed to the geno-
typing errors.
There are several limitations in this study. First, due to
a case–control study design, BMI prior to the diagnosis
of tuberculosis was absent, which restricted an in-depth
analysis of the ancillary effect of FTO variants on obes-
ity. Second, we only selected two SNPs in the FTO gene.
Other polymorphisms and their interactions with envir-
onmental factors should also be considered [56]. Third,
rs9939609 is located in the intron region of the FTO
gene and may not be the true causal variant. Based on
the RegulomeDB database, we observed a minimal bind-
ing evidence of rs8050136, which has a strong LD with
rs9939609. We hypothesize that the SNP rs9939609 may
be in linkage with the true functional SNP(s). Further
work with both knockout and overexpression models of
FTO and neighboring genes is likely to provide the most
fruitful approach to understand the mechanisms and
pathways through which these variants influence the risk
of tuberculosis.
Conclusions
Taken together, our results suggest that the FTO rs9939609
genetic polymorphism and the haplotype (rs9939609A-
rs8050136C) are involved in the risk of tuberculosis in
the Chinese population. Future studies should include a
comprehensive sequencing analysis to identify the spe-
cific causative sequence variants underlying the ob-
served associations. In future studies, nutritional status
and environmental factors will be essential for elucidat-
ing gene-environment interactions.
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